Introduction
Infection of arteriovenous shunt sites in patients on regular maintenance haemodialysis continues to be a major problem. When such infections occur the organisms involved are often staphylococci (Martin et al., 1967) . Effective and early treatment is vital if an infected shunt is to be saved and septicaemia averted. The choice of antibiotic may be difficult, particularly as many of the staphylococci will have a wide range of antibiotic resistance. Ideally the antibiotic selected should be bactericidal with marked antistaphylococcal activity and should be effective when given by mouth, thus avoiding the difficulties of intravenous administration and the haemorrhagic complications of intramuscular injections in anticoagulated patients. The dose regimen should not need adjustment according to the degree of renal failure and the drug should not be removed from the blood during haemodialysis (Eykin et al., 1970) .
We have compared the bacteriological and clinical effects of cloxacillin and sodium fusidate in patients on regular haemodialysis treatment who developed shunt infections, most of which were due to staphylococci.
Method
Trial cards were prepared in batches of six. Each batch contained a random allocation of sodium fusidate and cloxacillin therapy, such that with each batch three patients would be treated with each antibiotic. The initial grouping of patients was blind to the doctors managing the trial, although they were aware of the therapy to which individual patients had subsequently been allocated. was carried out using media of blood agar (aerobically and anaerobically), MacConkey, and electrolyte-deficient agar containing mannitol. Routine phage typing was carried out as described by Williams and Rippon (1952) . Methicillin and cloxacillin resistance was tested after overnight incubation of plates at 30°C, thus allowing the effects of temperature (Parker and Hewitt, 1970 Laboratory, Colindale, and at all times control plates were put up with those under investigation. Antibioic blood levels were estimated at 10-12 hours after the last dose of the antibiotic in 14 cases selected at random, the patients having been dialysed intercurrently.
Results
Thirty-seven patients were admitted to the trial. In Table I the bacteriological and clinical progress of the patients in the two groups is compared at 0 and 10 days. An analysis of other positive culture sites in those patients with initially positive shunt swabs is given in Table II .
All the organisms from positive shunt swabs were phage typed, and this information will form the basis of another paper. An interesting pattern emerged relating to phage type 29/77, which is usually associated with methicillin resistance but which was not the case in this unit. The number of patients in the clinical signs column does not in all cases correspond to the total number of patients investigated. These discrepancies were due to inadequate documentation. Three other patients subsequently developed positive shunt swabs during the trial period. In none of these were any of the other site swabs positive that is, they were not carriers. In Table III the overall bacteriological and clinical sequelae of the shunt trial are shown. There was no statistical difference in clinical improvement between the two treatment groups (X2 = 0-81) or in loss of shunts (X2 = 2-67; see Table   I ). Previous infective episodes had occurred in nine patients receiving cloxacillin and in 12 receiving sodium fusidate, there being no statistical difference between the groups. The commonest previous infecting organism was Staphylococcus aureus. Side effects of therapy were manifested by gastrointestinal symptoms (nausea and epigastric pain) in two patients and by pruritus in one. Precise instructions about taking sodium fusidate with meals might have prevented some of these symptoms.
Bacteriological recurrence was defined for the purposes of this trial as the recurrence of positive shunt swabs at day 30 occurring after a previous negative swab at day 10. Bacteriological reinfection was defined as a positive shunt swab with a different organism occurring at day 30 after previous negative swabs at day 10. There was no statistical significance between the recurrence and reinfection rates in the two groups.
Long-term antibiotic therapy was indicated in four patients (25%) in the cloxacillin group and in three (14%) in the sodium fusidate group. These patients. still had evidence of continuing clinical or bacteriological infection or both after completion of the trial or following 10 days of antibiotic therapy. In the patients whose antibiotic levels were measured the mean sodium fusidate level at 10-12 hours after the last dose was 3-6 )g/ml and the mean cloxacillin level 2-2 ug/ml. Both these levels are acceptable in terms of M.I.C. for S.aph. aureus in serum (Garrod and O'Grady, 1968 (Martin et al., 1967) . There was no predilection for staphylococcal infection to involve a particular limb of the shunt.
Adequate serum cloxacillin and sodium fusidate levels were obtained with our regimen and confirm the findings of previous workers (Linton et al., 1968; Hobby et al., 1970) . The most common carrier site in patients with staphylococcal shunt sepsis is the nose (Williams, 1963) . Our policy is to swab the nasal passage of our prospective shunt patients, and should a staphylococcus be found we prescribe a 10-day course of Naseptin (chlorhexidine hydrochloride 0-1%, neomycin sulphate 0 5%) twice a day before the shunt is inserted. Finally, in patients who have repeated Staph. aureus shunt infections just as much attention should be paid to elimination of the nasal carrier state as to treating individual shunt infections.
Our results show that clinical signs must always take precedence over the bacteriological evidence of a shunt infection. Both sodium fusidate and cloxacillin are good bactericidal agents, and in this small series of patients no statistically significant differences emerged between the two antibiotics. We believe that shunts which appear clinically infected should be initially treated without awaiting bacteriological results. A combination of either cloxacillin or sodium fusidate with ampicillin by mouth will adequately cover the vast majority of shunt infections. Effective, early, and appropriate antibiotic therapy will salvage many infected shunts and improve the present situation, which led to the statement "the occurrence of a shunt infection often resulted in the need to resite the shunt" (Ralston et al., 1971) . Our shunt salvage rate seems acceptable compared with previous reports (Farooki et al., 1970) and diminishes the need for using more potentially troublesome antibiotics.
Drug resistance to both sodium fusidate and cloxacillin did not occur in any of our trial patients or others subsequently studied. Should long-term antibiotic therapy be needed sodium fusidate seems appropriate, since bacterial resistance to it is very rare (Taylor and Bloor, 1962) .
